Debra Kessler
New York Blood Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Debra Kessler.
Transfusion | 2006
George B. Schreiber; Karen S. Schlumpf; Simone A. Glynn; David Wright; Yongling Tu; Melissa King; Martha J. Higgins; Debra Kessler; Ronald O. Gilcher; Catharie C. Nass; Anne M. Guiltinan
BACKGROUND: To prevent donor loss and improve retention, it is important to understand the major deterrents to blood donation and to identify factors that can be effectively addressed by blood centers.
Transfusion | 2007
Whitney R. Steele; George B. Schreiber; Anne M. Guiltinan; Catharie C. Nass; Simone A. Glynn; David Wright; Debra Kessler; Karen S. Schlumpf; Yongling Tu; James W. Smith; George Garratty
BACKGROUND: Blood donation can be described as a prosocial behavior, and donors often cite prosocial reasons such as altruism, empathy, or social responsibility for their willingness to donate. Previous studies have not quantitatively evaluated these characteristics in donors or examined how they relate to donation frequency.
Transfusion | 2003
Simone A. Glynn; Alan E. Williams; Catharie C. Nass; James Bethel; Debra Kessler; Edward P. Scott; Joy Fridey; Steven H. Kleinman; George B. Schreiber; Retrovirus Epidemiology Donor Study
BACKGROUND : The potential effectiveness of various donation incentive programs may vary by demographics, first‐time or repeat status, and collection site.
Transfusion | 2006
Simone A. Glynn; George B. Schreiber; Edward L. Murphy; Debra Kessler; Martha J. Higgins; David Wright; Sunitha Mathew; Yongling Tu; Melissa King; James W. Smith
BACKGROUND: Understanding factors that encourage different racial and ethnic groups to donate is crucial for donor recruitment and retention.
Transfusion | 2005
Ana M. Sanchez; George B. Schreiber; Catharie C. Nass; Simone A. Glynn; Debra Kessler; Nora V. Hirschler; Joy Fridey; James Bethel; Edward L. Murphy; Michael P. Busch
BACKGROUND: Men who have had sex with men (MSM) since 1977 are permanently deferred from donating blood. Excluding only men who engaged in male‐to‐male sex within either the prior 12 months or 5 years has been proposed. Little is known about infectious disease risks of MSM who donate blood.
The Journal of Infectious Diseases | 2012
Eric Delwart; Elizabeth Slikas; Susan L. Stramer; Hany Kamel; Debra Kessler; David E. Krysztof; Leslie H. Tobler; Danielle M. Carrick; Whitney R. Steele; Deborah Todd; David J. Wright; Steven H. Kleinman; Michael P. Busch
BACKGROUND Genetic variations of human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) can affect diagnostic assays and therapeutic interventions. Recent changes in prevalence of subtypes/genotypes and drug/immune-escape variants were characterized by comparing recently infected vs more remotely infected blood donors. METHODS Infected donors were identified among approximately 34 million US blood donations, 2006-2009; incident infections were defined as having no or low antiviral antibody titers. Viral genomes were partially sequenced. RESULTS Of 321 HIV strains (50% incident), 2.5% were non-B HIV subtypes. Protease and reverse transcriptase (RT) inhibitor resistance mutations were found in 2% and 11% of infected donors, respectively. Subtypes in 278 HCV strains (31% incident) yielded 1a>1b>3a>2b>2a>4a>6d, 6e: higher frequencies of 3a in incident cases vs higher frequencies of 1b in prevalent cases were found (P = .04). Twenty subgenotypes among 193 HBV strains (26% incident) yielded higher frequencies of A2 in incident cases and higher frequencies of A1, B2, and B4 in prevalent cases (P = .007). No HBV drug resistance mutations were detected. Six percent of incident vs 26% of prevalent HBV contained antibody neutralization escape mutations (P = .01). CONCLUSIONS Viral genetic variant distribution in blood donors was similar to that seen in high-risk US populations. Blood-borne viruses detected through large-scale routine screening of blood donors can complement molecular surveillance studies of highly exposed populations.
Emerging Infectious Diseases | 2003
Joseph Z. Lux; Don Weiss; Jeanne V. Linden; Debra Kessler; Barbara L. Herwaldt; Susan J. Wong; Jan Keithly; Phyllis Della-Latta; Brian E. Scully
We describe a 54-year-old spleen-intact man with transfusion-associated Babesia microti infection after a heart transplant. Adult respiratory distress syndrome developed in the patient, and he required mechanical ventilation. Our experiences with this patient suggest that babesiosis should be considered in the differential diagnosis of transplant patients who have fever and hemolytic anemia.
Transfusion | 2009
Kerri Dorsey; Shimian Zou; Lawrence B. Schonberger; Marian T. Sullivan; Debra Kessler; Edward P. Notari; Chyang T. Fang; Roger Y. Dodd
BACKGROUND: Since 2004, several reported transfusion transmissions of variant Creutzfeldt‐Jakob disease (vCJD) in the United Kingdom have reawakened concerns about the possible risk of similar transmissions of nonvariant or classic forms of CJD.
Transfusion | 2015
Brian Custer; Debra Kessler; Farnaz Vahidnia; German F. Leparc; David E. Krysztof; Beth H. Shaz; Hany Kamel; Simone A. Glynn; Roger Y. Dodd; Susan L. Stramer
Risk factor surveillance among infected blood donors provides information on the effectiveness of eligibility assessment and is critical for reducing risk of transfusion‐transmitted infection.
Journal of Behavioral Medicine | 2009
Caitlin Burditt; Mark L. Robbins; Andrea L. Paiva; Wayne F. Velicer; Beryl A. Koblin; Debra Kessler
Despite a specific need for transfused blood among African Americans due to higher rates of sickle cell disease, African Americans donate blood significantly less frequently than their White counterparts. This study describes the development and validation of culturally adapted measures of the transtheoretical model (TTM) constructs of Stage of Change, Decisional Balance, and Self-efficacy applied to blood donation in an African American sample. Exploratory and confirmatory analyses produced one pros and two cons scales for the Decisional Balance Inventory, and one scale for the Situational Self-efficacy Measure. Expected patterns for the Decisional Balance and Self-efficacy Scales by Stage of Change were found, but only the pros and one cons scale varied significantly. Results provide support for use of the TTM applied to blood donation and have important implications for development of effective assessment and intervention tools to increase blood donation among the African American population.